Literature DB >> 9189883

MRI of intramedullary sarcoidosis: follow-up of a case.

E Waubant1, C Manelfe, A Bonafé, I Berry, M Clanet.   

Abstract

Intramedullary lesions are infrequently the first manifestation of sarcoidosis. We present clinical and radiological follow-up of spinal cord sarcoidosis in a 68-year-old woman, mimicking an intramedullary tumour. MRI revealed an unusual area of low signal intensity on T2-weighted spin-echo images at the core of the lesion, consistent with calcification. Clinical and MRI follow-up showed progressive resolution of the intraspinal lesion, except for the calcification, with oral steroid therapy.

Entities:  

Mesh:

Year:  1997        PMID: 9189883     DOI: 10.1007/s002340050424

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  5 in total

1.  Spinal cord involvement in primary angiitis of the central nervous system: a report of two cases.

Authors:  A Campi; G Benndorf; V Martinelli; M R Terreni; G Scotti
Journal:  AJNR Am J Neuroradiol       Date:  2001-03       Impact factor: 3.825

Review 2.  Isolated spinal neurenteric cyst presenting as intramedullary calcified cystic mass on imaging studies: case report and review of literature.

Authors:  Mateo Ziu; Prasanna Vibhute; Giacomo G Vecil; James Henry
Journal:  Neuroradiology       Date:  2009-11-28       Impact factor: 2.804

Review 3.  Sarcoidosis of the spinal cord: literature review and report of eight cases.

Authors:  Samer Saleh; Chandan Saw; Kamel Marzouk; Om Sharma
Journal:  J Natl Med Assoc       Date:  2006-06       Impact factor: 1.798

Review 4.  Metaplastic bone formation in a low grade conus glioma: case report and review of the literature.

Authors:  Vitaly Siomin; Robert Willinsky; Patrick Shannon; Abhijit Guha
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

5.  Spinal cord hemorrhage in a patient with neurosarcoidosis on long-term corticosteroid therapy: case report.

Authors:  Benoit Pegat; Sophie Drapier; Xavier Morandi; Gilles Edan
Journal:  BMC Neurol       Date:  2015-07-30       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.